Marty Makary's tenure as head of FDA ends with 'difficulty'

The article centers Trump's direct statements and official government action (FDA leadership change) while using mild, vague language ('having some difficulty') that mirrors Trump's euphemistic framing rather than investigating specifics. The reporting is straightforward factual but lacks independent analysis of the pressures and rumors referenced, relying primarily on the president's characterization. This creates a slight establishment lean by accepting official framing at face value.

Primary voices: elected official, state or recognized government

• This article does not address specific policy disagreements or operational failures that led to Makary's departure
• This article does not include perspective from Makary or his defenders on the circumstances of his resignation
• This article does not clarify the nature of the 'pressure and rumors' mentioned beyond Trump's vague characterization